Business
1 views
A New Drug Takes Aim At One Of Cancer’s Most Difficult Targets
FDA-approved daraxonrasib targets RAS in metastatic pancreatic cancer, doubling median survival versus chemotherapy and delivering a long-awaited treatment advance.

Forbes Verified Source
Reported by William A. Haseltine, Contributor · Syndicated via official news feed
Explore all Business stories
Syndicated feed content with full publisher credit.
Live Newsroom Broadcast•48,500+ Active Readers
Breaking News Sent Directly To Your Phone
Get instant market movers, policy notifications, and verified alerts delivered straight to your WhatsApp and Telegram feeds before algorithms filter them.
Sub-Second Flash Alerts100% Privacy & Zero SpamFree Forever
Business Desk
More in Business
Continue reading verified coverage and related developments on this desk.